Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Microarray Grants, Jan. - March


Microarray-Related NIH Grants, Jan. 2, 2013 – March 21, 2013

Studies of rare genetic variation in the isolated population of Sardinia.
Principal investigator: Goncalo Roches Abecasis
Organization: University of Michigan
Project start date: Jan. 15, 2013
Project end date: Dec. 31, 2017
NIH institute: NHLBI
FY 2013 funding amount: $736,517

Twist-biosensor: novel single molecule microarray technology for DNA genotyping.
Principal investigator: Alfredo Celedon
Organization: Twistnostics
Project start date: Jan. 16, 2013
Project end date: June 30, 2013
NIH institute: NHGRI
FY 2013 funding amount: $153,257

Role of microRNAs and RISC in activity regulated translation in neurons.
Principal investigator: Gary Bassell
Organization: Emory University
Project start date: Feb. 1, 2013
Project end date: Jan. 31, 2015
NIH institute: NIDA
FY 2013 funding amount: $234,000

A novel spinal circuit involved in locomotion.
Principal investigator: George Mentis
Organization: Columbia University
Project start date: Feb. 15, 2013
Project end date: Jan. 31, 2015
NIH institute: NINDS
FY 2013 funding amount: $240,000

Genetic and molecular mechanisms of ethanol-producing developmental defects.
Principal investigator: Rachel French
Organization: San Jose State University
Project start date: March 1, 2013
Project end date: January 31, 2017
NIH institute: NIGMS
FY 2013 funding amount: $107,550

A highly multiplexed, scalable ultrananocrystalline diamond microarray sensor.
Principal investigator: Prabhu Arumugam
Organization: Advanced Diamond Technologies
Project start date: March 1, 2013
Project end date: Feb. 28, 2014
NIH institute: NIEHS
FY 2013 funding amount: $249,922

Immunopathogensis of Spinal Tuberculosis (TB)
Principal investigator: Jilian Sacks
Organization: University of Medicine and Dentistry of New Jersey
Project start date: March 15, 2013
Project end date: March 14, 2016
NIH institute: NIAID
FY 2013 funding amount: $52,190

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.